• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • R. Ripa, E. Jørgensen, +7 authors J. Kastrup
  • Medicine
  • Circulation
  • 2006 (First Publication: 25 April 2006)
  • Background— Phase 1 clinical trials of granulocyte-colony stimulating factor (G-CSF) treatment after myocardial infarction have indicated that G-CSF treatment is safe and may improve left ventricularExpand
  • A. Meris, M. Amigoni, +12 authors S. Solomon
  • Medicine
  • European heart journal
  • 2009 (First Publication: 11 November 2008)
  • AIMS To assess the relationship between left atrial (LA) size and outcome after high-risk myocardial infarction (MI) and to study dynamic changes in LA size during long-term follow-up. METHODS ANDExpand
  • Mads Kristian Ersbøll, Mads Jønsson Andersen, +7 authors Lars Valeur Køber
  • Medicine
  • European heart journal
  • 2014 (First Publication: 7 March 2014)
  • AIMS Diastolic dysfunction in acute myocardial infarction (MI) is associated with adverse outcome. Recently, the ratio of early mitral inflow velocity (E) to global diastolic strain rate (e'sr) hasExpand
  • J. J. Thune, L. Køber, +7 authors S. Solomon
  • Medicine
  • Journal of the American Society of…
  • 2006 (First Publication: 1 December 2006)
  • BACKGROUND Left ventricular (LV) ejection fraction (EF) and wall-motion index (WMI) have both been shown to be independent predictors of outcome after myocardial infarction (MI). OBJECTIVES WeExpand
  • Carolyn Y. Ho, Christian Malchau Carlsen, +10 authors Lars Køber
  • Medicine, Biology
  • Circulation. Cardiovascular genetics
  • 2009 (First Publication: 1 August 2009)
  • Background—Genetic testing identifies sarcomere mutation carriers (G+) before clinical diagnosis of hypertrophic cardiomyopathy (HCM), allowing characterization of initial disease manifestations.Expand